Founded in Boston, Etiometry Inc. is dedicated to revolutionizing healthcare through advanced information technology. The company’s core mission is to enhance patient outcomes in intensive care units (ICUs) by providing sophisticated software solutions. Their flagship product, the T3 platform, integrates data aggregation, visualization, risk analytics, and clinical pathway automation to support critical decision-making processes in real-time. Etiometry focuses on the healthcare market, particularly targeting ICUs to improve patient care and operational efficiency.
Etiometry has garnered significant attention and support from notable investors and healthcare professionals. The company's innovative approach has led to key achievements, including widespread adoption of their T3 platform in leading hospitals and positive clinical outcomes documented in peer-reviewed research. By leveraging cutting-edge technology to address critical needs in healthcare, Etiometry has made a substantial impact on the quality of ICU care, positioning itself as a leader in healthcare IT solutions.
